Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
502
502 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- HEC88473Phase 21 trial
Dongguan HEC Biopharmaceutical R&D Co., Ltd. · Type 2 Diabetes
- HM15136Phase 21 trial
Hanmi Pharmaceutical Company Limited · Congenital Hyperinsulinism
- HP-211Phase 21 trial
Housey Healthcare ULC · Type 2 Diabetes
- HRS-1301Phase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Hyperlipidemia
- HRS-4029Phase 21 trial
Beijing Suncadia Pharmaceuticals Co., Ltd · Acute Ischemic Stroke
- HRS-7450Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Acute Ischemic Stroke
- HRS-9563Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Mild to Moderate Hypertension
- IBI3016Phase 21 trial
Innovent Biologics (Suzhou) Co. Ltd. · Hypertension
- IlofotasePhase 21 trial
AM-Pharma · Open Heart Surgery
- INCA000585Phase 21 trial
Incyte · Immune Thrombocytopenia
- intraocular implant releasing timololTimoD implantPhase 21 trial
EyeD Pharma · Glaucoma, Ocular Hypertension
- INV-102Phase 21 trial
Invirsa, Inc. · Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy
- Invobenitug also known as ProcizumabAK1967Phase 21 trial
4TEEN4 Pharmaceuticals GmbH · Shock, Cardiogenic
- ION775Phase 21 trial
Ionis Pharmaceuticals · Hypertriglyceridemia, Severe Hypertriglyceridemia
- IW-6463CY6463, zagociguatPhase 21 trial
Tisento Therapeutics · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
- JBI-802Phase 21 trial
Jubilant Therapeutics Inc. · Essential Thrombocythemia (ET), Polycythemia Vera
- JK07Phase 21 trial
Salubris Biotherapeutics Inc · Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction
- JMT202Phase 21 trial
Shanghai JMT-Bio Inc. · Hypertriglyceridemia
- JTT-861Phase 21 trial
Shionogi Inc. · Chronic Heart Failure
- KAI-7535Phase 21 trial
Kailera · Obesity, Overweight
- KBP-336Phase 21 trial
KeyBioscience AG · Osteoarthritis in the Knee, Obesity
- KELI-101Phase 21 trial
Kelifarma · Preemptive Therapy of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
- LSALT PeptideMetablokPhase 21 trial
Arch Biopartners Inc. · Acute Kidney Injury, Cardiac Surgery
- LY3457263Phase 21 trial
Eli Lilly · Type 2 Diabetes
- LY3938577Phase 21 trial
Eli Lilly · Diabetes Mellitus, Type 2
- LY4086940Phase 21 trial
Eli Lilly · Obesity, Overweight
- MET233Phase 21 trial
Pfizer · Obesity and Obesity-related Medical Conditions
- MKP10241Phase 21 trial
Mankind Pharma Limited · Type 2 Diabetes Mellitus (T2DM), Food Effect, Safety and Tolerability
- MLD10Phase 21 trial
Pharmalyte Solutions LLC · Hypomagnesemia in Type 2 Diabetic Patients
- MN-001Phase 21 trial
MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease
- MT200605Phase 21 trial
Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Acute Ischemic Stroke
- MWX203Phase 21 trial
Shanghai Minwei Biotechnology Co., Ltd · Mixed Dyslipidemia
- NCS-01Phase 21 trial
NC Medial Research Inc · Ischemic Stroke
- NimacimabPhase 21 trial
Skye Bioscience, Inc. · Obesity
- NNC0662-3168Test product-APhase 21 trial
Novo Nordisk · Overweight, Obesity, Type 2 Diabetes Mellitus
- NoNO-42Phase 21 trial
NoNO Inc. · Acute Ischemic Stroke
- NST-1024Phase 21 trial
NorthSea Therapeutics B.V. · High Triglycerides
- NTS-521Phase 21 trial
NeuroTrauma Sciences, LLC · Acute Ischemic Stroke
- NVG-2089Phase 21 trial
Nuvig Therapeutics, Inc. · Immune Thrombocytopenia (ITP)
- OPT101Phase 21 trial
Op-T LLC · Type I Diabetes
- OrticumabMLDL1278a, BI204Phase 21 trial
Abcentra · Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation
- OXU-001DEXAspheresPhase 21 trial
Oxular Limited · Diabetic Macular Edema
- PAL-119Phase 21 trial
Paulex Bio Inc. · Healthy Volunteers and Diabetes Participants
- PF-07328948Phase 21 trial
Pfizer · Heart Failure
- PF-07868489Phase 21 trial
Pfizer · Pulmonary Arterial Hypertension
- PF-07976016Phase 21 trial
Pfizer · Obesity
- PF-08653945Phase 21 trial
Pfizer · Overweight, Obesity, Overweight and/or Obesity
- PG043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
- PKN605Phase 21 trial
Novartis · Atrial Fibrillation
- PN20Phase 21 trial
Chongqing Peg-Bio Biopharm Co., Ltd. · Thrombocytopenia Associated With Chronic Liver Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.